Published on 12 Jan 2022 on Insider Monkey via Yahoo Finance

SAGE Therapeutics Inc (SAGE): Hedge Funds Are Taking Some Chips Off The Table

The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the second quarter, which unveil their equity positions as of September 30th. We went through these filings, fixed typos and other more significant errors and identified the changes in hedge fund portfolios. Our extensive review of these public filings is finally over, so this article is set to reveal the smart money sentiment towards SAGE Therapeutics Inc (NASDAQ:SAGE).

SAGE Therapeutics Inc (NASDAQ:SAGE) shareholders have witnessed a decrease in activity from the world's largest hedge funds in recent months. SAGE Therapeutics Inc (NASDAQ:SAGE) was in 22 hedge funds' portfolios at the end of September. The all time high for this statistic is 38. There were 27 hedge funds in our database with SAGE holdings at the end of June. Our calculations also showed that SAGE isn't among the 30 most popular stocks among hedge funds (click for Q2 rankings).

At Insider Monkey, we scour multiple sources to uncover the next great investment idea. For example, lithium prices have more than doubled over the past year, so we go through lists like the 10 best EV stocks to pick the next Tesla that will deliver a 10x return. Even though we recommend positions in only a tiny fraction of the companies we analyze, we check out as many stocks as we can. Now let's go over the latest hedge fund action encompassing SAGE Therapeutics Inc (NASDAQ:SAGE).